Its mechanism of action involves inhibition of the phosphatidylinositol 3‐kinase/protein kinase B (PI3K/AKT) signaling pathway, which plays a critical role in breast cancer progression (Yu et al., 2021; Zhong et al., 2022). Here, AKT1 is linked to breast cancer.